Advanced Biomed INC S-1 registration statements

Advanced Biomed Inc., a pre-revenue biotechnology company, filed an S-1 registration statement for the resale of up to 40 million shares by a selling stockholder under a $25 million equity line of credit, while grappling with persistent net losses and a Nasdaq minimum bid price deficiency.

Advanced Biomed Inc. is seeking to raise capital through an initial public offering of 1,875,000 shares of common stock, aiming for a Nasdaq listing to further its cancer detection technology.

Advanced Biomed Inc., a Nevada-based holding company focused on integrating semiconductor technology and biotechnology for cancer diagnostics, has filed Amendment No. 15 to its Form S-1 registration statement for a proposed initial public offering.

Advanced Biomed Inc., a Nevada-based holding company, plans to raise capital through a $7.5 million common stock offering to fund cancer detection technology development and market expansion.

Advanced Biomed Inc., a Nevada-based holding company focused on integrating semiconductor technology and biotechnology for cancer detection, has filed Amendment No. 13 to its Form S-1 registration statement for a proposed public offering of 1,875,000 shares of common stock.